NY-ESTÉE-LAUDER
8.11.2019 12:47:11 CET | Business Wire | Press release
The Estée Lauder Companies Inc. (NYSE: EL) released its Fiscal 2019 Corporate Responsibility Report (CR Report).
The report entitled, “Inspired by Beauty, Driven by Our Values,” underscores the company’s progress and commitment to strengthening efforts across core citizenship and sustainability focus areas and highlights key milestones demonstrating industry leadership in inclusion and diversity (I&D) practices. “As we continue to deliver on our promise to create the world’s most beloved products and experiences, we believe that embedding citizenship and sustainability across our business reflects the value we place on long-term, sustainable growth,” said Fabrizio Freda, President and Chief Executive Officer of The Estée Lauder Companies Inc. “This year, we took important steps to more formally integrate these longstanding principles into our strategy and across our entire business.”
The company continually strives to enhance the depth and transparency of its citizenship and sustainability disclosure to better meet the expectations of key stakeholders, including consumers, investors and employees. The report applies the internationally recognized Global Reporting Initiative (GRI) Standards at the “Core in Accordance” level as well as generally aligning to the Sustainability Accounting Standards Board (SASB) disclosure recommendations.
“We credit the success of The Estée Lauder Companies in the dynamic and fast-paced world of prestige beauty to the passion and dedication of our employees, the vision of our leaders and the strength of our beloved brands,” said William P. Lauder, Executive Chairman of The Estée Lauder Companies Inc. “We look forward to building a beautiful and sustainable future together.”
CR Report Highlights
Energy & Emissions: The company is on track to meet its environmental sustainability goals of achieving Net Zero carbon emissions and sourcing 100% renewable energy (RE100) by the end of 20201 . Integral to progress in 2019 was the continued roll-out of a portfolio of projects that reflects the full scope of climate change mitigation strategies, including solar power, wind energy and more. Recent investments in support of the Net Zero goal include installing a 1.4 MW ground-mounted solar array at the company’s Melville campus in New York. This site is designed to produce more than 1,800 MWh of solar power annually from more than 3,300 panels and is expected to offset the release of 1,300 metric tons of CO2 into the atmosphere annually.
Responsible Sourcing: In line with its 2025 goal to address issues that may exist within complex supply chains, the company reviewed and prioritized more than 4,000 ingredients considered sensitive from a responsible sourcing perspective and began developing and implementing biodiversity and social action plans. In fiscal 2019, the company implemented a new process to monitor existing supplier performance via the EcoVadis tool and became the first prestige beauty company to fund the HERproject - a program aimed at unlocking the full potential of women in global supply chains.
Social Impact: In 2019, the company set its goal of impacting the well-being of 10 million individuals around the world through programs and grants focused on health, education and the environment. As the company marked the 25th anniversary of the M·A·C VIVA GLAM Fund (the largest corporate HIV/AIDS funder outside of the pharmaceutical industry) the fund’s fiscal 2018 grants have positively impacted more than 12 million individuals. Additionally, more than $10.3 million was raised globally via The Breast Cancer Campaign to support vital research, education and medical services aligned to its mission of creating a breast cancer-free world.
The Estée Lauder Charitable Foundation (the Foundation) continued its efforts to support girls’ education globally, especially to equip girls worldwide with the academic training, life skills and confidence to thrive in their communities. For example, the Foundation continued its support of the Student Leadership Network’s “The Young Women’s Leadership School” (TYWLS) of East Harlem, New York, and recently supported the model’s expansion to Los Angeles, California. Last year, 100% of graduating TYWLS seniors were accepted into college.
Beyond social impact initiatives at the enterprise level, a range of brands within the company’s portfolio pursued various cause programs in fiscal 20192 .
Inclusion & Diversity: The company’s efforts within inclusion and diversity (I&D) continued in fiscal 2019. The Human Rights Campaign (HRC) recognized the company as a “Best Place to Work for LGBTQ Equality” following a perfect score of 100% on HRC’s 2019 Corporate Equality Index3 . And the company received several notable media recognitions:
- Named Forbes’ “#1 Employer for Women 2019 (July 2019)
- Recognized within Forbes’ “Best Employers for Diversity 2019”
- Named to 2019 Bloomberg Gender-Equality Index for the second consecutive year
The company worked proactively to attract a more diverse pool of talent, hiring a dedicated recruiter to focus on diverse talent and attending career fairs at Historically Black Colleges and Universities in the United States. Additionally, significant efforts were made internally to celebrate and empower diverse employee groups through its 30 Employee Resource Groups.
Employee Engagement: The company’s employees are the key to realizing its sustainability and social impact goals. In fiscal 2019, the company made a commitment to provide access to basic sustainability and social impact training across all levels of its organization by the end of 2020. The company is also on track to meet its 2025 goal to engage 50% of eligible employees in regional, brand or local volunteer programs such as ELC Good Works, The Breast Cancer Campaign and the M·A·C Global Volunteer program.
This year’s CR Report demonstrates how the company’s progress toward its goals has a positive impact on society and on the planet. Nancy Mahon, Senior Vice President, Global Corporate Citizenship and Sustainability of The Estée Lauder Companies Inc. stated, “This year we have accelerated programs and initiatives at corporate and brand levels and have gained recognition for those efforts. As a family-founded company with a deep commitment to values and giving back, we are proud to continue our work to create a business that has social impact, inclusivity and sustainability at its core. It’s been an outstanding year.”
Read The Estée Lauder Companies Fiscal 2019 Corporate Responsibility Report
CAUTIONARY NOTE REGARDING CITIZENSHIP AND SUSTAINABILITY INFORMATION
This press release contains information about our citizenship and sustainability goals and efforts. These involve certain risks and uncertainties, such as changes in our business (e.g., acquisitions, divestitures or new manufacturing or distribution locations), the standards by which achievement is measured, the assumptions underlying a particular goal and our ability to accurately report particular information. Actual results could differ from our stated goals or the results we expect. We also may change, or decide not to pursue, certain goals or initiatives. Moreover, the standards by which citizenship and sustainability efforts and related matters are measured are developing and evolving, and certain areas are subject to assumptions. The standards and assumptions could change over time. In addition, statements made about our company, business or efforts may not apply to all business units (e.g., ones that are recently acquired). We assume no responsibility to update the information contained in this report or to continue to report any information.
About The Estée Lauder Companies Inc.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, Tommy Hilfiger, M·A·C, Kiton, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, Tom Ford, Smashbox, Ermenegildo Zegna, AERIN, Tory Burch, RODIN olio lusso, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, By Kilian, BECCA and Too Faced.
An electronic version of this release can be found at the company’s website, www.elcompanies.com .
ELC-C
ELC-I
| _____________________ |
| 1 For our citizenship and sustainability goals, by 20XX means by the end of Calendar Year 20XX. |
| 2 For more information on brand-driven social impact and sustainability initiatives in fiscal 2019, see the following sections of the 2019 Corporate Responsibility Report: Responsible Sourcing; Product Responsibility; Citizenship. |
| 3 2019 was The Estée Lauder Companies’ second consecutive year with a perfect score and the 10th time overall that we have achieved 100% in the 17 years HRC has been conducting its surveys. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20191108005068/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
